Showing results (351-360 of 429) with videos related to

Sort By:
Pageof 43
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 18, 2022
Referral and Evaluation for Kidney Transplantation Following Implementation of the 2014 National Kidney Allocation SystemRachel E Patzer, Mengyu Di, Rebecca Zhang, et al.
JAMA Network Open|July 2, 2025
Community Water Trihalomethanes and Chronic Kidney DiseaseDanielle N Medgyesi, Sumit Mohan, Komal Bangia, et al.
BMC Nephrology|January 4, 2022
Employment status at transplant influences ethnic disparities in outcomes after deceased donor kidney transplantationJasmin Divers, Sumit Mohan, W Mark Brown, et al.
Kidney International|March 23, 2024
Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipientsBecky M Ma, Naama Elefant, Martina Tedesco, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 2, 2016
Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and MycophenolateBekir Tanriover, Vishal Jaikaransingh, Malcolm P MacConmara, et al.
ESC Heart Failure|June 28, 2022
The difference between cystatin C- and creatinine-based assessment of kidney function in acute heart failureAlberto Pinsino, Matteo Fabbri, Lorenzo Braghieri, et al.
Journal of the American Society of Nephrology : JASN|February 20, 2010
Pathologic classification of diabetic nephropathyThijs W Cohen Tervaert, Antien L Mooyaart, Kerstin Amann, et al.
Kidney International Reports|May 20, 2024
Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX StudyHoward Trachtman, Jai Radhakrishnan, Michelle N Rheault, et al.
Journal of the American Society of Nephrology : JASN|October 27, 2018
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGSHoward Trachtman, Peter Nelson, Sharon Adler, et al.
Pageof 43